haha, you are a funny guy,but very realistic and knowledgeable at the same time knowing what are the bargaining chips that ONCS has at the moment. We look at things conservatively by using our product line's explosive potential and benchmarking it to a market value for which its worth.Then factoring in price earnings ratio to get fair market value,amongst many other special circumstances such as the MCC orphan drug status or accelerated approval and marketing exclusivity and protection rights by the FDA in highly favourable cases.
But could you enlighten me a little- are all these events as in clinical trials and additional FDA studies going to be completed by this year according to the timeline published by ONCS corporate website, because I know they have meetings, exhibitions, expositions and other institutional investment conferences which could be useful platforms for sharing and getting important news and updates to the press on upcoming developments. But just trying to say that we DO NOT need to go it alone to market our products after the clinical phase and new drug application step is done, slowly climbing up to achieve over US$1 BILLION+(ie $6 or more)-which I would be decently happy at over 700% ROI at $6, but since you stretched my imagination further,I think the investment community would agree fully with a $3billion company all the way to 5B, which yields $30/share- In 24 months(2016 February), I will be 26 years old, definitely $30(or 3650% upwards from here)is a dream come true. Financial freedom has never tasted so sweet.
But to keep things in perspective, a time frame to help us understand how things will unfold, partnerships, completion of clinical trials(hopefully all of them are much better than conventional cure, and statistically significant too) and extra undiluted and non-toxic funding would bring things closer to fruition. For a start, I know we would see $12-18 some days in the near future, but what about the first $3 in say June 2014 just to make it to NASDAQ alone with/without partnership?
